Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
176 | 58057 | 35.2 | 69% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
176 | 3 | DIABETES CARE//ENDOCRINOLOGY & METABOLISM//TYPE 2 DIABETES | 58057 |
79 | 2 | DIABETES CARE//DIABETES EDUCATOR//DIABETIC MEDICINE | 27337 |
1167 | 2 | GLUCAGON LIKE PEPTIDE 1//GLP 1//INCRETIN | 9383 |
1415 | 2 | DIPEPTIDYL PEPTIDASE IV//CD26//AMINOPEPTIDASE | 7997 |
1552 | 2 | INSULIN RECEPTOR//INSULIN DEGRADING ENZYME//INOSITOL PHOSPHOGLYCAN | 7396 |
1896 | 2 | METFORMIN//ACARBOSE//REPAGLINIDE | 5944 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | DIABETES CARE | journal | 529080 | 6% | 30% | 3396 |
2 | ENDOCRINOLOGY & METABOLISM | WoSSC | 507400 | 36% | 5% | 21034 |
3 | TYPE 2 DIABETES | authKW | 430547 | 6% | 25% | 3326 |
4 | DIABETIC MEDICINE | journal | 258121 | 3% | 30% | 1678 |
5 | DIABETES EDUCATOR | journal | 243161 | 1% | 64% | 723 |
6 | GLUCAGON LIKE PEPTIDE 1 | authKW | 240040 | 1% | 58% | 791 |
7 | GLP 1 | authKW | 226568 | 1% | 57% | 756 |
8 | DIABETES | authKW | 225219 | 7% | 11% | 3924 |
9 | DIABETES TECHNOLOGY & THERAPEUTICS | journal | 207140 | 1% | 54% | 729 |
10 | INCRETIN | authKW | 206528 | 1% | 68% | 579 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Endocrinology & Metabolism | 507400 | 36% | 5% | 21034 |
2 | Medicine, General & Internal | 24229 | 11% | 1% | 6337 |
3 | Primary Health Care | 10684 | 1% | 3% | 840 |
4 | Pharmacology & Pharmacy | 9027 | 10% | 1% | 5712 |
5 | Health Care Sciences & Services | 8802 | 3% | 1% | 1776 |
6 | Public, Environmental & Occupational Health | 5844 | 5% | 1% | 3193 |
7 | Health Policy & Services | 4813 | 2% | 1% | 1019 |
8 | Biochemistry & Molecular Biology | 4676 | 12% | 0% | 7070 |
9 | Medicine, Research & Experimental | 3951 | 4% | 1% | 2487 |
10 | Nursing | 2950 | 2% | 1% | 939 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | DIABET | 92133 | 2% | 14% | 1291 |
2 | ENDOCRINOL | 47866 | 4% | 5% | 2106 |
3 | ENDOCRINOL METAB | 36454 | 2% | 6% | 1233 |
4 | DIABET TRANSLAT | 33861 | 0% | 34% | 194 |
5 | DIABET UNIT | 31510 | 1% | 18% | 348 |
6 | ENDOCRINOL DIABET | 29499 | 1% | 11% | 532 |
7 | DIABET GRP | 17476 | 0% | 23% | 144 |
8 | NNF BASIC METAB | 17358 | 0% | 50% | 66 |
9 | BANTING BEST DIABET | 14878 | 0% | 31% | 93 |
10 | BIOMETR EPIDEMIOL | 14162 | 0% | 28% | 99 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | DIABETES CARE | 529080 | 6% | 30% | 3396 |
2 | DIABETIC MEDICINE | 258121 | 3% | 30% | 1678 |
3 | DIABETES EDUCATOR | 243161 | 1% | 64% | 723 |
4 | DIABETES TECHNOLOGY & THERAPEUTICS | 207140 | 1% | 54% | 729 |
5 | DIABETES OBESITY & METABOLISM | 196775 | 2% | 41% | 911 |
6 | DIABETES RESEARCH AND CLINICAL PRACTICE | 166754 | 2% | 25% | 1303 |
7 | DIABETES & METABOLISM | 88197 | 1% | 25% | 695 |
8 | DIABETOLOGIA | 65341 | 2% | 12% | 1028 |
9 | DIABETES THERAPY | 63355 | 0% | 82% | 148 |
10 | PRIMARY CARE DIABETES | 54951 | 0% | 56% | 188 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | TYPE 2 DIABETES | 430547 | 6% | 25% | 3326 | Search TYPE+2+DIABETES | Search TYPE+2+DIABETES |
2 | GLUCAGON LIKE PEPTIDE 1 | 240040 | 1% | 58% | 791 | Search GLUCAGON+LIKE+PEPTIDE+1 | Search GLUCAGON+LIKE+PEPTIDE+1 |
3 | GLP 1 | 226568 | 1% | 57% | 756 | Search GLP+1 | Search GLP+1 |
4 | DIABETES | 225219 | 7% | 11% | 3924 | Search DIABETES | Search DIABETES |
5 | INCRETIN | 206528 | 1% | 68% | 579 | Search INCRETIN | Search INCRETIN |
6 | TYPE 2 DIABETES MELLITUS | 199901 | 3% | 25% | 1557 | Search TYPE+2+DIABETES+MELLITUS | Search TYPE+2+DIABETES+MELLITUS |
7 | TYPE 1 DIABETES | 168596 | 2% | 24% | 1383 | Search TYPE+1+DIABETES | Search TYPE+1+DIABETES |
8 | DPP 4 INHIBITOR | 168005 | 1% | 89% | 360 | Search DPP+4+INHIBITOR | Search DPP+4+INHIBITOR |
9 | METFORMIN | 160111 | 2% | 29% | 1076 | Search METFORMIN | Search METFORMIN |
10 | HYPOGLYCAEMIA | 156198 | 1% | 50% | 600 | Search HYPOGLYCAEMIA | Search HYPOGLYCAEMIA |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | HOLST, JJ , (2007) THE PHYSIOLOGY OF GLUCAGON-LIKE PEPTIDE 1.PHYSIOLOGICAL REVIEWS. VOL. 87. ISSUE 4. P. 1409 -1439 | 262 | 86% | 952 |
2 | KIM, W , EGAN, JM , (2008) THE ROLE OF INCRETINS IN GLUCOSE HOMEOSTASIS AND DIABETES TREATMENT.PHARMACOLOGICAL REVIEWS. VOL. 60. ISSUE 4. P. 470 -512 | 368 | 75% | 260 |
3 | BAGGIO, LL , DRUCKER, DJ , (2007) BIOLOGY OF INCRETINS: GLP-1 AND GIP.GASTROENTEROLOGY. VOL. 132. ISSUE 6. P. 2131 -2157 | 194 | 85% | 1270 |
4 | CHO, YM , MERCHANT, CE , KIEFFER, TJ , (2012) TARGETING THE GLUCAGON RECEPTOR FAMILY FOR DIABETES AND OBESITY THERAPY.PHARMACOLOGY & THERAPEUTICS. VOL. 135. ISSUE 3. P. 247 -278 | 386 | 79% | 34 |
5 | KIEFFER, TJ , HABENER, JL , (1999) THE GLUCAGON-LIKE PEPTIDES.ENDOCRINE REVIEWS. VOL. 20. ISSUE 6. P. 876 -913 | 355 | 72% | 647 |
6 | MILLIGAN, G , SHIMPUKADE, B , ULVEN, T , HUDSON, BD , (2017) COMPLEX PHARMACOLOGY OF FREE FATTY ACID RECEPTORS.CHEMICAL REVIEWS. VOL. 117. ISSUE 1. P. 67 -110 | 221 | 60% | 2 |
7 | TAHRANI, AA , BARNETT, AH , BAILEY, CJ , (2016) PHARMACOLOGY AND THERAPEUTIC IMPLICATIONS OF CURRENT DRUGS FOR TYPE 2 DIABETES MELLITUS.NATURE REVIEWS ENDOCRINOLOGY. VOL. 12. ISSUE 10. P. 566 -592 | 264 | 83% | 3 |
8 | DE GRAAF, C , DONNELLY, D , WOOTTEN, D , LAU, J , SEXTON, PM , MILLER, LJ , AHN, JM , LIAO, JY , FLETCHER, MM , YANG, DH , ET AL (2016) GLUCAGON-LIKE PEPTIDE-1 AND ITS CLASS B G PROTEIN-COUPLED RECEPTORS: A LONG MARCH TO THERAPEUTIC SUCCESSES.PHARMACOLOGICAL REVIEWS. VOL. 68. ISSUE 4. P. 954 -1013 | 352 | 70% | 0 |
9 | WAUMANS, Y , BAERTS, L , KEHOE, K , LAMBEIR, AM , DE MEESTER, I , (2015) THE DIPEPTIDYL PEPTIDASE FAMILY, PROLYL OLIGOPEPTIDASE, AND PROLYL CARBOXYPEPTIDASE IN THE IMMUNE SYSTEM AND INFLAMMATORY DISEASE, INCLUDING ATHEROSCLEROSIS.FRONTIERS IN IMMUNOLOGY. VOL. 6. ISSUE . P. - | 230 | 89% | 12 |
10 | VERSPOHL, EJ , (2009) NOVEL THERAPEUTICS FOR TYPE 2 DIABETES: INCRETIN HORMONE MIMETICS (GLUCAGON-LIKE PEPTIDE-1 RECEPTOR AGONISTS) AND DIPEPTIDYL PEPTIDASE-4 INHIBITORS.PHARMACOLOGY & THERAPEUTICS. VOL. 124. ISSUE 1. P. 113 -138 | 274 | 86% | 80 |
Classes with closest relation at Level 3 |